Please select the option that best describes you:
How would you approach the adjuvant treatment of a stage IVA adenosarcoma of the ovary?
Would your systemic therapy choice be more similar to treatment of ovarian carcinoma or soft tissue sarcoma?
Answer from: Medical Oncologist at Academic Institution
Adenosarcomas have a benign/low grade epithelial component, unlike carcinosarcoma/sarcomatoid carcinoma. The sarcomatous component is the high grade element driving prognosis, so therapy should be directed a'la sarcoma based on usual predictive factors of age, PS, organ function, etc.
Sign in or Register to read more